Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 3:7:43099.
doi: 10.1038/srep43099.

Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers

Affiliations

Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers

T Hidalgo et al. Sci Rep. .

Abstract

Nanometric biocompatible Metal-Organic Frameworks (nanoMOFs) are promising candidates for drug delivery. Up to now, most studies have targeted the intravenous route, related to pain and severe complications; whereas nanoMOFs for oral administration, a commonly used non-invasive and simpler route, remains however unexplored. We propose here the biofriendly preparation of a suitable oral nanocarrier based on the benchmarked biocompatible mesoporous iron(III) trimesate nanoparticles coated with the bioadhesive polysaccharide chitosan (CS). This method does not hamper the textural/structural properties and the sorption/release abilities of the nanoMOFs upon surface engineering. The interaction between the CS and the nanoparticles has been characterized through a combination of high resolution soft X-ray absorption and computing simulation, while the positive impact of the coating on the colloidal and chemical stability under oral simulated conditions is here demonstrated. Finally, the intestinal barrier bypass capability and biocompatibility of CS-coated nanoMOF have been assessed in vitro, leading to an increased intestinal permeability with respect to the non-coated material, maintaining an optimal biocompatibility. In conclusion, the preservation of the interesting physicochemical features of the CS-coated nanoMOF and their adapted colloidal stability and progressive biodegradation, together with their improved intestinal barrier bypass, make these nanoparticles a promising oral nanocarrier.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1
(a) Comparison of TFY and TEY Fe L2,3-edge XANES of the nano-MOFs before (NP) and after (NP-CS) CS absorption. (b) Reference Fe L2,3-edge XANES in three different model compounds with different number of d–electrons, coordination numbers and with different formal charges, i.e. metal (Fe0), FeCl2 (FeII) and Fe2O3 (FeIII). (c) XANES O K-edge spectra of the nano-MOFs (NP)- before and after CS absorption, using TFY detector.
Figure 2
Figure 2. Geometry optimized configuration for CS (here corresponding to 3 units linked through β-(1–4) bridges: 2 units of D-glucosamine and 1 of N-acetyl-D-glucosamine) and a metal cluster issued from MIL-100(Fe) NPs with 2 FeII and 1 FeIII.
Figure 3
Figure 3. Release of Rh-CS in water (black), SIF (blue), lis-SIF-panc (green) and HBSS (red) at 37 °C as a function of time.
The maximum of release of 100 wt% corresponds to the total release of the total amount of CS initially coating the NPs.
Figure 4
Figure 4. Degradation kinetics of uncoated (black) and coated (red) MIL-100(Fe) NPs in water, HBSS, DMEM, PBS, SIF, lis-SIF and lis-SIF-panc at 37 °C as a function of time.
Figure 5
Figure 5. Confocal microscopy images of Caco-2 cells containing uncoated and CS-coated MIL-100(Fe) NPs observed by iron self-reflection signal (green channel) and the nucleus stained by DAPI (blue channel).
The images have been taken at different times: 0.5, 2.5 and 24 h. Moreover, the controls were obtained with cells (control) after 24 h. In all the cases, the scale bar corresponded to 25 μm. All the images were taken at 63X.

References

    1. Horcajada P., Gref R., Baati T., Allan P. K., Maurin G., Couvreur P., Ferey G., Morris R. E. & Serre C. Metal-organic frameworks in biomedicine. Chem. Rev. 112, 1232–1268 (2012). - PubMed
    1. Giménez-Marqués M., Hidalgo T., Serre C. & Horcajada P. Nanostructured metal-organic frameworks and their bio-related applications. Coord. Chem. Rev. 307(2), 342–360 (2016).
    1. Kagan L. & Hoffman A. Sytems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations. Expert Opin. Drug Deliv. 5, 681–692 (2008). - PubMed
    1. Horcajada P. et al.. Flexible porous metal-organic frameworks for a controlled drug delivery. J. Am. Chem. Soc. 130, 6774–6780 (2008). - PubMed
    1. Mitragotri S., Burkre P. A. & Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug Discov. 13, 650–672 (2014). - PMC - PubMed

Publication types

LinkOut - more resources